phloroglucinol has been researched along with Infarction, Middle Cerebral Artery in 2 studies
Phloroglucinol: A trinitrobenzene derivative with antispasmodic properties that is used primarily as a laboratory reagent.
phloroglucinol : A benzenetriol with hydroxy groups at position 1, 3 and 5.
Infarction, Middle Cerebral Artery: NECROSIS occurring in the MIDDLE CEREBRAL ARTERY distribution system which brings blood to the entire lateral aspects of each CEREBRAL HEMISPHERE. Clinical signs include impaired cognition; APHASIA; AGRAPHIA; weak and numbness in the face and arms, contralaterally or bilaterally depending on the infarction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hyperforin (0." | 1.48 | Hyperforin protects against acute cerebral ischemic injury through inhibition of interleukin-17A-mediated microglial activation. ( Liu, K; Ma, L; Pan, X; Wang, L; Zhou, F, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, L | 1 |
| Pan, X | 1 |
| Zhou, F | 1 |
| Liu, K | 1 |
| Wang, L | 1 |
| Lin, Y | 1 |
| Zhang, JC | 1 |
| Fu, J | 1 |
| Chen, F | 1 |
| Wang, J | 1 |
| Wu, ZL | 1 |
| Yuan, SY | 1 |
2 other studies available for phloroglucinol and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Hyperforin protects against acute cerebral ischemic injury through inhibition of interleukin-17A-mediated microglial activation.
Topics: Animals; Brain Infarction; Brain Injuries; Cytokines; Disease Models, Animal; Exploratory Behavior; | 2018 |
Hyperforin attenuates brain damage induced by transient middle cerebral artery occlusion (MCAO) in rats via inhibition of TRPC6 channels degradation.
Topics: Animals; Apoptosis; Brain Ischemia; Calcium-Calmodulin-Dependent Protein Kinase Type 4; Calpain; Cyc | 2013 |